HIGHLIGHTS
- who: Zifeng Yang and collaborators from the Department of Interventional Radiology, The Fifth People`s Hospital of Jinan, Jinan, Shandong, China Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China have published the research work: miR-302a-3p Promotes Radiotherapy Sensitivity of Hepatocellular Carcinoma by Regulating Cell Cycle via MCL1, in the Journal: Computational and Mathematical Methods in Medicine of 10/Oct/2022
- what: This study preliminarily explored the potential impact and mechanism of miR-302a-3p on HCC radiotherapy resistance.
- how: These results indicated that overexpression of miR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.